PRLB Company Profile and Key Details

Proto Labs, Inc. (NYSE:PRLB) closed at $53.03 USD, gaining $0.91 (1.75%) from the previous close of $52.12. The stock is currently mid-range between its 52-week high and low $29.59 and $55.90. With a market capitalization of about $1.26 billion, Proto Labs, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.18). Key stats such as the average daily volume over the past year has been around 194.24 thousand shares, volume is running light vs its 52-week average. Headquartered in Maple Plain, MN, Proto Labs, Inc. operates in the Industrials sector and the Manufacturing - Metal Fabrication industry. Led by CEO Suresh Krishna, the company employs approximately 2,357 people and listed since February 24, 2012. Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide.

Proto Labs, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $32.91. This means the shares are trading above this model’s fair value.

Short-term trend indicators are bearishly aligned (SMA20 1.38%, SMA50 1.84%, SMA200 18.83%). The stock’s 14-day RSI is 54.71 (neutral), while the ATR of 1.4 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -6.76% below its high and over 76.17% above its low. Average 10-day trading volume of 196.99 thousand shares is in line with the 3-month average of 179.34 thousand, indicating normal recent market interest.

Proto Labs, Inc. generated EPS of $0.61 over the past year. Five-year average earnings growth is -22.5%. Wall Street analysts project EPS growth of 5.79% annually over the next five years. The latest quarter delivered EPS of $0.47. The next quarter is forecast at $0.35. Next year's EPS is expected at $6.35. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $55.00 to $50.00. The high target offers 5.53% upside. The low target suggests -4.07% downside. The mean target is $52.00. This offers -0.23% upside. Proto Labs, Inc. earnings surprise history is a mixed track record. The quarter that ended October 31, 2025, missed forecasts by 20.51%. The prior quarter beat by 24.24%. Over the last six quarters, Apple has recorded several small beats. These include -47.38% in August 02, 2024.

Proto Labs, Inc. has 23.87 million shares outstanding. The public float is 23.62 million shares, elevated short interest at 4.00% of float. This equals 667.97 thousand shares. The short ratio is 3.25 days. Institutional investors hold 93.57% of the float. Insiders own 1.35%. LUKIS LAWRENCE J holds 2.08 million shares, Bodor Robert has 80.88 thousand shares and HOLT VICTORIA M has 58.46 thousand shares. Over the past six months, insider transactions show net buying. They sold 3.05 thousand shares across 1 transactions.

Proto Labs, Inc. (NYSE:PRLB) shares are up 33.33% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Proto Labs, Inc. trading at a premium to the broader market with a P/E of 85.12. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $73.20, suggesting 40.45% upside. Our AI forecast model points to short-term strength (4.6% over two weeks), a medium-term fall (-19.38% over three months), and a longer-term gain (10.48% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Proto Labs, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.6%, with price expected at $54.52 by January 02, 2026, within a range of $53.20 to $55.77 3-Month Outlook: Projected fall of -19.38%, reaching $42.02 by March 19, 2026, with a range of $36.00 to $46.40. 1-Year Outlook: Projected gain of 10.48%, with price at $57.58 by December 18, 2026, within a range of $55.61 to $59.27.

Proto Labs, Inc. trades at a P/E ratio of 85.12, slightly above the S&P 500 average, with a price-to-sales ratio of 2.41 and a price-to-book ratio of 1.9 suggesting the stock is closer to book value. The P/FCF stands at 17.14, also above market averages.